-
1
-
-
0033588034
-
Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids
-
Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285:1276-1279.
-
(1999)
Science
, vol.285
, pp. 1276-1279
-
-
Node, K.1
Huo, Y.2
Ruan, X.3
-
2
-
-
0030889716
-
The role of the cytochrome p450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: A review
-
Rahman M, Wright JT, Jr., Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. Am J Hypertens. 1997;10: 356-365.
-
(1997)
Am J Hypertens
, vol.10
, pp. 356-365
-
-
Rahman, M.1
Wright Jr., J.T.2
Douglas, J.G.3
-
3
-
-
0036277938
-
Neuroprotection and p450 2c11 upregulation after experimental transient ischemic attack
-
Alkayed NJ, Goyagi T, Joh HD, et al. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke. 2002;33:1677-1684.
-
(2002)
Stroke
, vol.33
, pp. 1677-1684
-
-
Alkayed, N.J.1
Goyagi, T.2
Joh, H.D.3
-
4
-
-
0035674963
-
Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase
-
Fisslthaler B, Popp R, Michaelis UR, Kiss L, Fleming I, Busse R. Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase. Hypertension. 2001;38:1427-1432.
-
(2001)
Hypertension
, vol.38
, pp. 1427-1432
-
-
Fisslthaler, B.1
Popp, R.2
Michaelis, U.R.3
Kiss, L.4
Fleming, I.5
Busse, R.6
-
5
-
-
0028321518
-
Cytochrome p-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney
-
Paller MS, Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA. 1994;91:7002-7006.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 7002-7006
-
-
Paller, M.S.1
Jacob, H.S.2
-
6
-
-
0029889723
-
Biochemical characterization of the human liver cytochrome p450 arachidonic acid epoxygenase pathway
-
Zeldin DC, Moomaw CR, Jesse N, et al. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys. 1996;330:87-96.
-
(1996)
Arch Biochem Biophys
, vol.330
, pp. 87-96
-
-
Zeldin, D.C.1
Moomaw, C.R.2
Jesse, N.3
-
7
-
-
0033993749
-
Cytochrome p450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase
-
Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res. 2000;41:163-181.
-
(2000)
J Lipid Res
, vol.41
, pp. 163-181
-
-
Capdevila, J.H.1
Falck, J.R.2
Harris, R.C.3
-
8
-
-
0030923112
-
Molecular cloning, expression, and functional significance of a cytochrome p450 highly expressed in rat heart myocytes
-
Wu S, Chen W, Murphy E, et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem. 1997;272:12551-12559.
-
(1997)
J Biol Chem
, vol.272
, pp. 12551-12559
-
-
Wu, S.1
Chen, W.2
Murphy, E.3
-
9
-
-
0035965327
-
Epoxygenase pathways of arachidonic acid metabolism
-
Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem. 2001;276:36059-36062.
-
(2001)
J Biol Chem
, vol.276
, pp. 36059-36062
-
-
Zeldin, D.C.1
-
10
-
-
0029122098
-
Molecular cloning, expression and characterization of an endogenous human cytochrome p450 arachidonic acid epoxygenase isoform
-
Zeldin DC, DuBois RN, Falck JR, Capdevila JH. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys. 1995;322:76-86.
-
(1995)
Arch Biochem Biophys
, vol.322
, pp. 76-86
-
-
Zeldin, D.C.1
DuBois, R.N.2
Falck, J.R.3
Capdevila, J.H.4
-
11
-
-
77957831701
-
Endothelial expression of human cytochrome p450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice
-
Lee CR, Imig JD, Edin ML, et al. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 2010;24:3770-3781.
-
(2010)
FASEB J
, vol.24
, pp. 3770-3781
-
-
Lee, C.R.1
Imig, J.D.2
Edin, M.L.3
-
12
-
-
0034791777
-
Polymorphisms in human cyp2c8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
-
Dai D, Zeldin DC, Blaisdell JA, et al. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics. 2001;11:597-607.
-
(2001)
Pharmacogenetics
, vol.11
, pp. 597-607
-
-
Dai, D.1
Zeldin, D.C.2
Blaisdell, J.A.3
-
13
-
-
18344377326
-
Cloning of cyp2j2 gene and identification of functional polymorphisms
-
King LM, Ma J, Srettabunjong S, et al. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol. 2002;61:840-852.
-
(2002)
Mol Pharmacol
, vol.61
, pp. 840-852
-
-
King, L.M.1
Ma, J.2
Srettabunjong, S.3
-
14
-
-
11144300168
-
The effect of the cytochrome p450 cyp2c8 polymorphism on the disposition of (r)-ibuprofen enantiomer in healthy subjects
-
Martinez C, Garcia-Martin E, Blanco G, Gamito FJ, Ladero JM, Agundez JA. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects. Br J Clin Pharmacol. 2005;59:62-69.
-
(2005)
Br J Clin Pharmacol
, vol.59
, pp. 62-69
-
-
Martinez, C.1
Garcia-Martin, E.2
Blanco, G.3
Gamito, F.J.4
Ladero, J.M.5
Agundez, J.A.6
-
15
-
-
79955481254
-
Pharmgkb summary: Cytochrome p450, family 2, subfamily j, polypeptide 2: Cyp2j2
-
Berlin DS, Sangkuhl K, Klein TE, Altman RB. PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2. Pharmacogenet Genomics. 2010;21:308-311.
-
(2010)
Pharmacogenet Genomics
, vol.21
, pp. 308-311
-
-
Berlin, D.S.1
Sangkuhl, K.2
Klein, T.E.3
Altman, R.B.4
-
16
-
-
80054712257
-
Diagnosis and prevention of chronic kidney allograft loss
-
Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011;378:1428-1437.
-
(2011)
Lancet
, vol.378
, pp. 1428-1437
-
-
Nankivell, B.J.1
Kuypers, D.R.2
-
17
-
-
84857192742
-
Delayed graft function in the kidney transplant
-
Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11:2279-2296.
-
(2011)
Am J Transplant
, vol.11
, pp. 2279-2296
-
-
Siedlecki, A.1
Irish, W.2
Brennan, D.C.3
-
18
-
-
75149136028
-
Pathological and clinical characterization of the 'troubled transplant': Data from the dekaf study
-
Gourishankar S, Leduc R, Connett J, et al. Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant. 2010;10:324-330.
-
(2010)
Am J Transplant
, vol.10
, pp. 324-330
-
-
Gourishankar, S.1
Leduc, R.2
Connett, J.3
-
19
-
-
56149085504
-
Role of cytochrome p450 2c8 and 2j2 genotypes in calcineurin inhibitor-induced chronic kidney disease
-
Smith HE, Jones JP III, Kalhorn TF, et al. Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics. 2008;18:943-953.
-
(2008)
Pharmacogenet Genomics
, vol.18
, pp. 943-953
-
-
Smith, H.E.1
Jones III, J.P.2
Kalhorn, T.F.3
-
20
-
-
0026662551
-
Cytochrome p-450 3a enzymes are responsible for biotransformation of fk506 and rapamycin in man and rat
-
Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos. 1992;20:753-761.
-
(1992)
Drug Metab Dispos
, vol.20
, pp. 753-761
-
-
Sattler, M.1
Guengerich, F.P.2
Yun, C.H.3
Christians, U.4
Sewing, K.F.5
-
21
-
-
0023921505
-
Cyclosporine metabolism in human liver: Identification of a cytochrome p-450iii gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
-
Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther. 1988;43: 630-635.
-
(1988)
Clin Pharmacol Ther
, vol.43
, pp. 630-635
-
-
Kronbach, T.1
Fischer, V.2
Meyer, U.A.3
-
22
-
-
0242332169
-
Impact of cytochrome p450 3a5 genetic polymorphism on tacrolimus doses and concentrationto-dose ratio in renal transplant recipients
-
Thervet E, Anglicheau D, King B, et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentrationto-dose ratio in renal transplant recipients. Transplantation. 2003;76:1233-1235.
-
(2003)
Transplantation
, vol.76
, pp. 1233-1235
-
-
Thervet, E.1
Anglicheau, D.2
King, B.3
-
23
-
-
77249158801
-
Effect of cyp3a and abcb1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part i
-
Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet. 2010;49:141-175.
-
(2010)
Clin Pharmacokinet
, vol.49
, pp. 141-175
-
-
Staatz, C.E.1
Goodman, L.K.2
Tett, S.E.3
-
24
-
-
77249125964
-
Effect of cyp3a and abcb1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part ii
-
Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Clin Pharmacokinet. 2010;49:207-221.
-
(2010)
Clin Pharmacokinet
, vol.49
, pp. 207-221
-
-
Staatz, C.E.1
Goodman, L.K.2
Tett, S.E.3
-
25
-
-
0027418815
-
Human p-glycoprotein transports cyclosporin a and fk506
-
Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem. 1993;268:6077-6080.
-
(1993)
J Biol Chem
, vol.268
, pp. 6077-6080
-
-
Saeki, T.1
Ueda, K.2
Tanigawara, Y.3
Hori, R.4
Komano, T.5
-
26
-
-
0035130778
-
Detection of mboii polymorphism at the 50 promoter region of cyp3a4
-
Cavalli SA, Hirata MH, Hirata RD. Detection of MboII polymorphism at the 50 promoter region of CYP3A4. Clin Chem. 2001; 47:348-351.
-
(2001)
Clin Chem
, vol.47
, pp. 348-351
-
-
Cavalli, S.A.1
Hirata, M.H.2
Hirata, R.D.3
-
28
-
-
0038304548
-
Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients
-
Anglicheau D, Verstuyft C, Laurent-Puig P, et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol. 2003;14:1889-1896.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1889-1896
-
-
Anglicheau, D.1
Verstuyft, C.2
Laurent-Puig, P.3
-
29
-
-
77955497262
-
The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: Single-center study
-
Jung GO, Yoon MR, Kim SJ, et al. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study. Transplant Proc. 2010; 42:705-709.
-
(2010)
Transplant Proc
, vol.42
, pp. 705-709
-
-
Jung, G.O.1
Yoon, M.R.2
Kim, S.J.3
-
30
-
-
0029810565
-
Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function
-
discussion 6
-
Marshall R, Ahsan N, Dhillon S, Holman M, Yang HC. Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function. Surgery. 1996;120:663-665; discussion 6.
-
(1996)
Surgery
, vol.120
, pp. 663-665
-
-
Marshall, R.1
Ahsan, N.2
Dhillon, S.3
Holman, M.4
Yang, H.C.5
-
31
-
-
84858438174
-
Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation
-
Gervasini G, Garcia M, Macias RM, Cubero JJ, Caravaca F, Benitez J. Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation. Transpl Int. 2012;25:471-480.
-
(2012)
Transpl Int
, vol.25
, pp. 471-480
-
-
Gervasini, G.1
Garcia, M.2
Macias, R.M.3
Cubero, J.J.4
Caravaca, F.5
Benitez, J.6
-
32
-
-
1842430562
-
Distribution of soluble epoxide hydrolase and of cytochrome p450 2c8, 2c9, and 2j2 in human tissues
-
Enayetallah AE, French RA, Thibodeau MS, Grant DF. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem. 2004;52:447-454.
-
(2004)
J Histochem Cytochem
, vol.52
, pp. 447-454
-
-
Enayetallah, A.E.1
French, R.A.2
Thibodeau, M.S.3
Grant, D.F.4
-
33
-
-
70350516381
-
Impact of donor-dependent genetic factors on long-term renal graft function
-
Krajewska M, Koscielska-Kasprzak K, Weyde W, et al. Impact of donor-dependent genetic factors on long-term renal graft function. Transplant Proc. 2009;41:2978-2980.
-
(2009)
Transplant Proc
, vol.41
, pp. 2978-2980
-
-
Krajewska, M.1
Koscielska-Kasprzak, K.2
Weyde, W.3
-
34
-
-
79953171482
-
Polymorphisms in cyp3a5 cyp3a4 and abcb1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation
-
Bouamar R, Hesselink DA, van Schaik RH, et al. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation. Ther Drug Monit. 2011;33:178-184.
-
(2011)
Ther Drug Monit
, vol.33
, pp. 178-184
-
-
Bouamar, R.1
Hesselink, D.A.2
Van Schaik, R.H.3
-
35
-
-
64349098468
-
Delayed graft function in renal transplant recipients: Risk factors and impact on 1-year graft function: A single center analysis
-
Bronzatto EJ, da Silva Quadros KR, Santos RL, Alves-Filho G, Mazzali M, Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis. Transplant Proc. 2009;41:849-851.
-
(2009)
Transplant Proc
, vol.41
, pp. 849-851
-
-
Bronzatto, E.J.1
Da Silva Quadros, K.R.2
Santos, R.L.3
Alves-Filho, G.4
Mazzali, M.5
-
36
-
-
68949218831
-
Factors that predict duration of delayed graft function in cadaveric kidney transplantation
-
Dominguez J, Lira F, Troncoso P, Aravena C, Ortiz M, Gonzalez R. Factors that predict duration of delayed graft function in cadaveric kidney transplantation. Transplant Proc. 2009;41:2668-2669.
-
(2009)
Transplant Proc
, vol.41
, pp. 2668-2669
-
-
Dominguez, J.1
Lira, F.2
Troncoso, P.3
Aravena, C.4
Ortiz, M.5
Gonzalez, R.6
-
37
-
-
80053184901
-
Cyp3a5 and abcb1 polymorphisms in donor and recipient: Impact on tacrolimus dose requirements and clinical outcome after renal transplantation
-
Glowacki F, Lionet A, Buob D, et al. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation. Nephrol Dial Transplant. 2011;26:3046-3050.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 3046-3050
-
-
Glowacki, F.1
Lionet, A.2
Buob, D.3
-
38
-
-
67449097673
-
Abcb1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome
-
Cattaneo D, Ruggenenti P, Baldelli S, et al. ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome. J Am Soc Nephrol. 2009;20:1404-1415.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1404-1415
-
-
Cattaneo, D.1
Ruggenenti, P.2
Baldelli, S.3
-
39
-
-
21444449731
-
Abcb1 genotype of the donor but not of the recipient is a major risk factor for cyclosporinerelated nephrotoxicity after renal transplantation
-
Hauser IA, Schaeffeler E, Gauer S, et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporinerelated nephrotoxicity after renal transplantation. J Am Soc Nephrol. 2005;16:1501-1511.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1501-1511
-
-
Hauser, I.A.1
Schaeffeler, E.2
Gauer, S.3
-
40
-
-
72049101913
-
Donor age and renal p-glycoprotein expression associate with chronic histological damage in renal allografts
-
Naesens M, Lerut E, de Jonge H, Van Damme B, Vanrenterghem Y, Kuypers DR. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol. 2009;20:2468-2480.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 2468-2480
-
-
Naesens, M.1
Lerut, E.2
De Jonge, H.3
Van Damme, B.4
Vanrenterghem, Y.5
Kuypers, D.R.6
|